With a thyroid‑stimulating hormone of 1.52 mIU/L and total thyroxine (T4) of 5.1 µg/dL while taking levothyroxine 75 µg daily plus liothyronine 10 µg daily, is this regimen appropriate or should the doses be adjusted?

Assessment of Current Thyroid Replacement Regimen

Your TSH of 1.52 mIU/L is within the normal range and indicates adequate thyroid hormone replacement; however, your total T4 of 5.1 µg/dL is low, suggesting you may need a dose adjustment of your levothyroxine rather than continuing the current combination therapy.

Interpretation of Your Laboratory Values

Your TSH level of 1.52 mIU/L falls within the normal reference range (typically 0.3-4.12 mIU/L) and is close to the population mean of approximately 1.5 mIU/L 1. This suggests adequate pituitary-thyroid axis suppression. However, your total T4 of 5.1 µg/dL is below the normal range (typically 5-12 µg/dL for total T4), which is concerning given you're taking both levothyroxine and liothyronine.

Key Issues with Your Current Regimen

The low T4 level despite a normal TSH suggests your levothyroxine dose may be insufficient. This pattern can occur with combination therapy because:

• Liothyronine (T3) has rapid onset and potent TSH-suppressing effects 2
• The T3 component may be masking inadequate T4 replacement by keeping TSH artificially normalized
• Your tissues may not be receiving adequate T4 for peripheral conversion to T3

Recommended Management Approach

Step 1: Obtain Complete Thyroid Panel

Before making dose adjustments, you need:

• Free T4 (not just total T4)
• Free T3
• Repeat TSH

This will clarify whether the low total T4 reflects true hypothyroidism or is an artifact of protein binding.

Step 2: Consider Simplifying to Levothyroxine Monotherapy

Guidelines strongly recommend levothyroxine monotherapy as first-line treatment 1. The evidence does not support routine use of combination therapy:

• Multiple randomized trials over 20 years have failed to demonstrate benefit of T4/T3 combination over levothyroxine alone 3
• A 2024 high-quality study (LEVOLIO) found no significant improvement in tissue markers or quality of life with combination therapy despite achieving higher T3/T4 ratios 4
• Combination therapy requires more frequent dose adjustments (54% vs 25% with monotherapy) and increases risk of TSH suppression 4

Step 3: Optimize Levothyroxine Dosing

If transitioning to monotherapy or adjusting current therapy:

• Increase levothyroxine by 12.5-25 µg increments 1
• For your current regimen (75 µg LT4 + 10 µg LT3), consider switching to approximately 100-112 µg levothyroxine monotherapy
• The 10 µg liothyronine provides roughly equivalent to 30-40 µg of levothyroxine effect on TSH suppression

Step 4: Recheck Labs in 4-8 Weeks

Dose adjustments must be followed by TSH measurement at 4-8 week intervals 1. The goal is:

• TSH: 0.3-2.0 mIU/L range (not just anywhere in the normal range) 3
• Free T4: mid-to-upper normal range
• Free T3: normal range

Important Caveats and Pitfalls

Medication Timing

Ensure you're taking levothyroxine properly:

• 30-60 minutes before breakfast with water only 1
• Alternatively, at bedtime 4 hours after last meal
• Avoid taking with substances that impair absorption (calcium, iron, proton pump inhibitors, soy) 1

When Combination Therapy Might Be Considered

Only after the following conditions are met 3:

1. Confirmed overt hypothyroidism (not subclinical)
2. Adequate trial of optimized levothyroxine monotherapy for 3-6 months with TSH 0.3-2.0 mIU/L
3. Persistent symptoms despite biochemical euthyroidism
4. Exclusion of other comorbidities causing symptoms
5. Shared decision-making between you and your clinician

Risks of Overtreatment

Your current low T4 with normal TSH raises concern about the balance of your regimen. Overtreatment with thyroid hormone carries significant risks 1:

• Cardiovascular complications (atrial fibrillation, especially if elderly)
• Accelerated bone loss (particularly in postmenopausal women)
• Affective disturbances

Monitoring Schedule

Once stable on adjusted therapy:

• Recheck at 4-8 weeks after any dose change 1
• Once stable, monitor every 6-12 months 1
• More frequent monitoring if you're elderly, have cardiac disease, or experience dose-interfering medications

The evidence strongly suggests your regimen needs adjustment—specifically, your levothyroxine dose appears inadequate given the low T4 level, and you should discuss with your clinician whether continuing combination therapy is truly necessary or whether optimized levothyroxine monotherapy would be more appropriate.